CYP1A1 and Hepatic fibrosis: Moreover, CYP1A1, ODC1 and MAOB may be potential targets related to the anti-liver fibrosis effects of dehydrocarptin, tetrahydropalmatine and palmatine, respectively (Figure 7C).